Detalles de la búsqueda
1.
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics.
Clin Proteomics
; 19(1): 2, 2022 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996345
2.
Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-art.
Pharmacogenomics J
; 19(1): 5-14, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190521
3.
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial.
Eur J Cancer
; 202: 113973, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447379
4.
Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity.
BMJ Case Rep
; 15(12)2022 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36517080
5.
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study.
J Thorac Oncol
; 17(7): 921-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489694
6.
Identifying metabolic alterations in newly diagnosed small cell lung cancer patients.
Metabol Open
; 12: 100127, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34585134
7.
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
Radiat Oncol
; 16(1): 131, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266462
8.
Interobserver variation in organs at risk contouring in head and neck cancer according to the DAHANCA guidelines.
Radiother Oncol
; 197: 110337, 2024 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772479
9.
Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation.
BMJ Case Rep
; 20142014 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-25056302
Resultados
1 -
9
de 9
1
Próxima >
>>